课题基金 / 基金详情

Understanding the mechanism of action and pathophysiological function of the NOR1 and Nur77 orphan nuclear receptors

Understanding the mechanism of action and pathophysiological function of the NOR1 and Nur77 orphan nuclear receptors
了解 NOR1 和 Nur77 孤儿核受体的作用机制和病理生理功能
批准号:
nhmrc : 301040
负责人:
Prof George Muscat
金额:
$17.95万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31

项目摘要

项目成果

Prof George Muscat的其他基金

相似基金

相关文献

中文摘要
翻译
核激素受体(Nuclear hormone receptor, NRs)是配体激素激活的转录因子,在生殖、发育和代谢过程中调控基因表达。激素信号功能失调和NR功能不适当导致生殖障碍、炎症、癌症、糖尿病和心血管疾病。为治疗NR相关疾病而制定的药典范围强调了NR在疾病中的重要性。孤儿rna在序列上属于超家族,然而,与这些蛋白结合的内源性信号分子是未知的。孤儿nrrs Nur77、NURR1和NOR1是应激反应基因,可被广泛的生理刺激诱导。此外,NR4A受体亚群与致癌、神经系统疾病;炎症、糖尿病和动脉粥样硬化。这一提案的目的是检查控制基因表达的调控的分子机制的孤儿核受体,Nur77 NOR-1。此外,我们将研究NOR-1和Nur77在肌肉中的病理生理功能。在骨骼肌Nur77和NOR-1表达。这个主要的肿块组织约占体重的40%,是葡萄糖和脂肪代谢的主要部位。因此,该外围组织发挥了重要作用,胰岛素敏感性,和血液血脂。此外,一项与工业界的合作已经确定了NOR-1是肌肉中的胰岛素应答基因,该基因对糖尿病患者的胰岛素诱导变得高度敏感。此外,我们有令人兴奋的证据表明抗肿瘤嘌呤抗代谢物6-巯基嘌呤激活NR4A亚群。Nur77和NOR-1代表了一个令人兴奋的挑战,并且揭示了NOR-1依赖转录的分子机制,为识别新的信号通路和治疗方法提供了机会。
英文摘要
Nuclear hormone receptors (NRs) function as ligand-hormone activated transcription factors that regulate gene expression involved in reproduction, development and metabolism. Dysfunctional hormonal signalling, and inappropriate NR function results in reproductive disorders, inflammation, cancer, diabetes, and cardiovascular disease. The significance of NRs in disease is underscored by the range of pharmacopoeia developed for the treatment of NR associated disorders. Orphan NRs belong to the superfamily on the basis of their sequence identity, however, the endogenous signaling molecules which bind to these proteins are unknown. The orphan NRs Nur77, NURR1, and NOR1, functions as stress response genes which are induced by a wide range of physiological stimuli Furthermore, the NR4A subgroup of receptors has been implicated in carcinogenesis, neurological disorders; inflammation, diabetes and atherogenesis. The objective of this proposal is to examine the molecular mechanisms that control the regulation of gene expression by the orphan nuclear receptors, Nur77 and NOR-1. Furthermore, we will investigate the pathophysiological function of NOR-1 and Nur77 in muscle. Nur77 and NOR-1 are expressed in skeletal muscle. This major mass tissue accounts for ~40% of total body weight and, is a major site of glucose and fat metabolism. Consequently, this peripheral tissue plays a significant role in insulin sensitivity, and the blood lipid profile. Furthermore, a collaboration with industry has identified NOR-1 as an insulin responsive gene in muscle, which becomes hyper-sensitive to insulin induction in diabetic patients. Additionally, we have exciting evidence that the anti-neoplastic purine anti-metabolite, 6-mercaptopurine activates the NR4A subgroup. Nur77 and NOR-1 represent an exciting challenge, and unlocking the molecular mechanisms that NOR-1-dependent transcription provides the opportunity for identifying novel signaling pathways, and therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endocrine control of metabolic disease
  • 批准号:
    nhmrc : 1059341
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $50.9万
  • 财政年份:
    2014
  • 负责人:
    Prof George Muscat
  • 依托单位:
Hormonal control of metabolism
  • 批准号:
    nhmrc : GNT1059341
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $72.76万
  • 财政年份:
    2014
  • 负责人:
    Prof George Muscat
  • 依托单位:
Retinoic acid receptor-related orphan receptors and the regulation of metabolism:insights into diabetes and obesity
  • 批准号:
    nhmrc : 1027484
  • 项目类别:
    Project Grants
  • 资助金额:
    $50.73万
  • 财政年份:
    2012
  • 负责人:
    Prof George Muscat
  • 依托单位:
Nuclear Receptor 4A3 signalling in skeletal muscle
  • 批准号:
    nhmrc : 631480
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.72万
  • 财政年份:
    2010
  • 负责人:
    Prof George Muscat
  • 依托单位:
国内基金
海外基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
  • 批准号:
    82371028
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵慧
  • 依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    谢静远
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位: